If you would like to send a message to the board of directors, please use the contact form or email board@cpnp.org. The 2019-2020 Board represents a variety of practice settings such that their jobs consist of Academia (56%), Clinical (31%), Administrative (4%) and other duties (9%).

Lisa Goldstone, MS, LPC, PharmD, BCPS, BCPP
President
Associate Professor of Clinical Pharmacy
Associate Director of Residency Programs
University of Southern California School of Pharmacy
Los Angeles, CA

Academia: 100%
I have a pharmacogenomics consult service in an outpatient psychiatric clinic one morning per week. As part of our clinic practice, pharmacy residents with an ambulatory care focus are embedded as part of the psychiatric team in our medical complicated psychiatric clinic. I oversee the teaching activities and the subsequent evaluation of all residents including our PGY1 ambulatory care psychiatry focus and PGY2 psychiatric pharmacy residents. My research areas of interest include the clinical application of pharmacogenomics and the scholarship of teaching and learning.

Marshall Cates, PharmD, BCPP, FASHP, FCCP
President-Elect
Professor of Pharmacy Practice
Samford University McWhorter School of Pharmacy
Birmingham, AL

Academia: 100%
Since I'm a department chair, I don't currently have a practice site. However, I am involved in a clinic every few months that is dedicated to mental health care for the medically underserved. My primary teaching responsibilities include lecturing in psychiatric pharmacotherapy and teaching an elective course titled “Mental Illness and Treatment in the Movies.” I am routinely involved in various mental health-related scholarly pursuits, including clinical, laboratory, and pedagogical research projects.

Megan Ehret, PharmD, MS, BCPP
Past President
Associate Professor
University of Maryland
Baltimore, MD

Academia: 60%; Clinical: 40%
I am on a team of over 20 psychiatric pharmacists who work in Mental Health Program. I support a 37-bed inpatient psychiatry unit which receives patients from Baltimore, Washington DC, and Northern Virginia.

Ericka Crouse, PharmD, BCGP, BCPP, FASCP, FASHP
Secretary
Associate Professor
Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy
Richmond, VA

Academia: 40%; Clinical: 50%; Other: 10%
I serve as a member of the interdisciplinary team on a 40-bed inpatient psychiatry service that treats patients with treatment- resistant depression, severe mental illness, and geriatric psychiatry disorders. I also spend one half-day per week in a substance use disorder clinic managing patients primarily on buprenophrine/naloxone. 

Tawny Smith, PharmD, BCPP
Treasurer
Associate Professor of Psychiatry
The University of Texas at Austin, Dell Medical School
Austin, TX

Academia: 25%; Clinical: 65%; Other: 10%
I practice in both the inpatient and outpatient settings. I am the director of the psychopharmacology consult service at a psychiatric hospital and supervise 3rd year psychiatry residents completing the rotation with me. In the outpatient setting, I provide direct patient care in a women's reproductive mental health clinic and treatment resistant depression clinic. Additionally, I provide consultative services in the geriatric psychiatry and cognitive disorders clinics.

Karen Moeller, PharmD, BCPP
Member-at-Large
Clinical Professor
University of Kansas School of Pharmacy
Kansas City, KS

Academia: 50%; Clinical: 25%; Administrative: 25%
My clinical role is to provide clinical pharmacy services for an inpatient adult psychiatry service. My current unit averages 15 patients daily with a high patient turnover rate with roughly 4-5 new patients and discharges daily. Our unit provides treatment for patients with serious psychiatric conditions such as major depressive disorder, bipolar disorder, schizophrenia, substance use disorder and personality disorders. We treat both voluntary and involuntary patients. In late September 2019, our adult unit will move to a free standing psychiatric hospital that will serve up to 50 patients daily.

Heidi Wehring, PharmD, BCPP
Member-at-Large
Assistant Professor of Psychiatry
Maryland Psychiatric Research Center
University of Maryland School of Medicine
Baltimore, MD

Academia: 20%; Clinical: 40%; Other: 40%
I am the sole clinical psychiatric pharmacist for two multidisciplinary clinics serving youth in the state of Maryland. One is a child telepsychiatry clinic serving the Eastern Shore of Maryland; the other is a SAMHSA-funded clinic focusing on youth at Clinical High Risk for Psychosis. In addition, I co-direct a statewide prior authorization program for Medicaid-insured youth prescribed antipsychotic medications. I am also an active researcher funded to study new treatments for youth and adults with serious mental illness with or without co-occurring substance use, including medication and non-medication interventions.

Brenda K Schimenti
Ex Officio
Executive Director
CPNP 8055 O Street, Ste. S113
Lincoln, NE 68510
P: (402) 476-1677
F: (888) 555-7617